Top Markets
#1 Black Phoenix Black Phoenix +199.74%
#2 Islamic Coin Islamic Coin +158.05%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.25%
#5 Akedo Akedo +41.31%
#6 BasedHype BasedHype +32.44%
#7 Acurast Acurast +26.87%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.07%
#9 Cryptopia Cryptopia +22.04%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +17.37%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
GENinCode plc GENinCode plc

GENinCode plc

GENI
Classifica tra le azioni #41228
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Prezzo delle azioni
$0.01206398
Capitalizzazione di mercato
$33.74K
Variazione (1 giorno)
-1.49%
Variazione (1 anno)
-40.77%
Paese
GB
Scambia GENinCode plc (GENI)

Categoria

Healthcare
Rapporto P/S per GENinCode plc (GENI)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di GENinCode plc, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per GENinCode plc da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.61 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.46 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.92 -
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
15.33 -
US